Skip to content
ppharmaranks
Menu

Best Bile Acid Sequestrant for enterocolitis, pseudomembranous

Top-rated pick: Colestipol Hydrochloride — pharmaranks score 66/100, the highest of the 4 Bile Acid Sequestrant drugs used for enterocolitis, pseudomembranous, ranked by our independent FDA recall-safety score. Compare them with all treatments for enterocolitis, pseudomembranous or the full Bile Acid Sequestrant class. Not medical advice — always consult a professional.

Quick answer: Of the 4 bile acid sequestrant drugs we rate for enterocolitis, pseudomembranous, all are available as lower-cost generics, and most are suspension. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for enterocolitis, pseudomembranous; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Other drug classes for enterocolitis, pseudomembranous

Top bile acid sequestrant for enterocolitis, pseudomembranous: 1. Colestipol Hydrochloride · 2. Colestid · 3. Flavored Colestid

Best-rated Bile Acid Sequestrant for enterocolitis, pseudomembranous, ranked by pharmaranks score
#DrugRatingPharmacy pays
166/100$20View →
264/100$20View →
364/100$20View →
462/100$8View →

Full ranking · 4 drugs

Frequently asked

What is the best bile acid sequestrant for enterocolitis, pseudomembranous?
By our independent recall-safety rating — not an efficacy measure — colestipol hydrochloride ranks highest among Bile Acid Sequestrant drugs used for enterocolitis, pseudomembranous. Always consult a professional.
Which bile acid sequestrant drugs treat enterocolitis, pseudomembranous?
pharmaranks lists 4 Bile Acid Sequestrant products used for enterocolitis, pseudomembranous, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.